- Endoscopy for assessment of mucosal healing in ulcerative colitis: time bound or response guided?
-
Sood A, Mahajan R, Singh A, Midha V, Mehta V
- KMID: 2531983
- Intest Res.
- 2022 Jul;20(3):297-302.
- doi: 10.5217/ir.2021.00099
The timing of colonoscopy in patients with active ulcerative colitis (UC) lacks coherence. The published guidelines and recommendations advocate time-bound colonoscopy in patients with active UC to assess for mucosal... -
- CITED
-
- Close
- SHARE
-
- Close
- Incidental benefits after fecal microbiota transplant for ulcerative colitis
-
Mahajan R, Midha V, Singh A, Mehta V, Gupta Y, Kaur K, Sudhakar R, Singh Pannu A, Singh D, Sood A
- KMID: 2504589
- Intest Res.
- 2020 Jul;18(3):337-340.
- doi: 10.5217/ir.2019.00108
Gut dysbiosis can result in several diseases, including infections (Clostridium difficile infection and infectious gastroenteritis), autoimmune diseases (inflammatory bowel disease, diabetes, and allergic disorders), behavioral disorders and other conditions like... -
- CITED
-
- Close
- SHARE
-
- Close
- Low prevalence of primary sclerosing cholangitis in patients with inflammatory bowel disease in India
-
Singh A, Midha V, Narang V, Kedia S, Mahajan R, Dhoble P, Kahlon BK, Dhaliwal AS, Tripathi A, Kalra S, Jain NP, Bansal N, Banerjee R, Desai D, Dutta U, Ahuja V, Sood A
- KMID: 2547195
- Intest Res.
- 2023 Oct;21(4):452-459.
- doi: 10.5217/ir.2022.00087
Background/Aims: Primary sclerosing cholangitis (PSC) represents the most common hepatobiliary extraintestinal manifestation of inflammatory bowel disease (IBD), including ulcerative colitis (UC) and Crohn’s disease (CD). Limited data exist on PSC... -
- CITED
-
- Close
- SHARE
-
- Close
- Trends of inflammatory bowel disease at a tertiary care center in northern India
-
Sood A, Kaur K, Singh A, Midha V, Mahajan R, Bansal N, Mehta V, Singh D
- KMID: 2518684
- Intest Res.
- 2021 Jul;19(3):282-290.
- doi: 10.5217/ir.2020.00010
Background/Aims: Inflammatory bowel disease (IBD), including ulcerative colitis (UC) and Crohn’s disease (CD), is increasingly being reported from India and other Asian countries. This study looks into the changing trends... -
- CITED
-
- Close
- SHARE
-
- Close
- A simple phenotypic classification for celiac disease
-
Sood A, Midha V, Makharia G, Thelma BK, Halli SS, Mehta V, Mahajan R, Narang V, Sood K, Kaur K
- KMID: 2417681
- Intest Res.
- 2018 Apr;16(2):288-292.
- doi: 10.5217/ir.2018.16.2.288
BACKGROUND/AIMS: Celiac disease is a global health problem. The presentation of celiac disease has unfolded over years and it is now known that it can manifest at different ages, has... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical spectrum of elderly-onset inflammatory bowel disease in India
-
Gupta YK, Singh A, Narang V, Midha V, Mahajan R, Mehta V, Singh D, Bansal N, Durairaj MVB, Dutta AK, Sood A
- KMID: 2541894
- Intest Res.
- 2023 Apr;21(2):216-225.
- doi: 10.5217/ir.2021.00177
Background/Aims: Inflammatory bowel disease (IBD) is increasingly being recognized in elderly patients. Data on clinical spectrum of elderly-onset IBD patients is lacking from India. Methods: A cross-sectional retrospective analysis of a... -
- CITED
-
- Close
- SHARE
-
- Close
- Association of endoscopic and histological remission with clinical course in patients of ulcerative colitis
-
Narang V, Kaur R, Garg B, Mahajan R, Midha V, Sood N, Sood A
- KMID: 2402647
- Intest Res.
- 2018 Jan;16(1):55-61.
- doi: 10.5217/ir.2018.16.1.55
BACKGROUND/AIMS: The therapeutic goal for treating ulcerative colitis (UC) patients has shifted to achieving mucosal healing over the past few years. However, at present, limited data is available on the... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical profile and outcomes of opioid abuse gastroenteropathy: an underdiagnosed disease entity
-
Mahajan R, Gupta Y, Singh A, Dhiman P, Midha V, Kakkar C, Narang V, Mehta V, Saggar K, Sood A
- KMID: 2501389
- Intest Res.
- 2020 Apr;18(2):238-244.
- doi: 10.5217/ir.2019.00104
Background/Aims: Opioid-induced bowel dysfunction includes nausea, vomiting, constipation and abdominal distension. We describe patients presenting with gastrointestinal (GI) ulcers and ulcerated strictures secondary to opioid abuse, an entity not well... -
- CITED
-
- Close
- SHARE
-
- Close
- Inflammatory bowel disease (IBD)-disk accurately predicts the daily life burden and parallels disease activity in patients with IBD
-
Singh A, Gupta YK, Dhaliwal AS, Kahlon BK, Bansal V, Mahajan R, Mehta V, Singh D, Kaur R, Bansal N, Midha V, Sood A
- KMID: 2544760
- Intest Res.
- 2023 Jul;21(3):375-384.
- doi: 10.5217/ir.2022.00037
Background/Aims: The inflammatory bowel disease (IBD)-disk is a validated, visual, 10-item, self-administered questionnaire used to evaluate IBD-related disability. The present study aimed to evaluate IBD-disk in assessment of IBD daily... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy and safety of the adalimumab biosimilar Exemptia as induction therapy in moderate-to-severe ulcerative colitis
-
Midha V, Mahajan R, Mehta V, Narang V, Singh A, Kaur K, Sood A
- KMID: 2402651
- Intest Res.
- 2018 Jan;16(1):83-89.
- doi: 10.5217/ir.2018.16.1.83
BACKGROUND/AIMS: Data on the efficacy and safety of the adalimumab biosimilar Exemptia are limited. METHODS: Patients with moderate-to-severe active steroid-refractory ulcerative colitis (UC) treated at Dayanand Medical College and Hospital, India... -
- CITED
-
- Close
- SHARE
-
- Close
- Colitis and Crohn’s Foundation (India) consensus statements on use of 5-aminosalicylic acid in inflammatory bowel disease
-
Sood A, Ahuja V, Midha V, Sinha SK, Pai CG, Kedia S, Mehta V, Bopanna S, Abraham P, Banerjee R, Bhatia S, Chakravartty K, Dadhich S, Desai D, Dwivedi M, Goswami B, Kaur K, Khosla R, Kumar A, Mahajan R, Misra SP, Peddi K, Singh SP, Singh A
- KMID: 2508562
- Intest Res.
- 2020 Oct;18(4):355-378.
- doi: 10.5217/ir.2019.09176
Despite several recent advances in therapy in inflammatory bowel disease (IBD), 5-aminosalicylic acid (5-ASA) therapy has retained its place especially in ulcerative colitis. This consensus on 5-ASA is obtained through... -
- CITED
-
- Close
- SHARE
-
- Close
- Exclusive enteral nutrition for induction of remission in anti-tumor necrosis factor refractory adult Crohn’s disease: the Indian experience
-
Sood A, Singh A, Sudhakar R, Midha V, Mahajan R, Mehta V, Gupta YK, Kaur K
- KMID: 2501383
- Intest Res.
- 2020 Apr;18(2):184-191.
- doi: 10.5217/ir.2019.00094
Background/Aims: Exclusive enteral nutrition (EEN) is recommended for induction of remission in pediatric Crohn’s disease (CD). However, it is not currently recommended for inducing remission in adults. This report describes... -
- CITED
-
- Close
- SHARE
-
- Close
- Maintaining infliximab induced clinical remission with azathioprine and 5-aminosalicylates in acute severe steroid-refractory ulcerative colitis has lower cost and high efficacy (MIRACLE): a multicenter study
-
Mahajan R, Singh A, Kedia S, Kaur K, Midha V, Sahu P, Mehta V, Singh D, Bansal N, Dharni K, Kaushal S, Ahuja V, Sood A
- KMID: 2525073
- Intest Res.
- 2022 Jan;20(1):64-71.
- doi: 10.5217/ir.2020.00100
Background/Aims: Infliximab (IFX) has been used to induce and maintain remission in patients with severe steroid-refractory ulcerative colitis (UC). Long-term use of biologics in developing countries is limited by high... -
- CITED
-
- Close
- SHARE
-
- Close
- Use of thiopurines in inflammatory bowel disease: an update
-
Singh A, Mahajan R, Kedia S, Dutta AK, Anand A, Bernstein CN, Desai D, Pai CG, Makharia G, Tevethia HV, Mak JW, Kaur K, Peddi K, Ranjan MK, Arkkila P, Kochhar R, Banerjee R, Sinha SK, Ng SC, Hanauer S, Verma S, Dutta U, Midha V, Mehta V, Ahuja V, Sood A
- KMID: 2525069
- Intest Res.
- 2022 Jan;20(1):11-30.
- doi: 10.5217/ir.2020.00155
Inflammatory bowel disease (IBD), once considered a disease of the Western hemisphere, has emerged as a global disease. As the disease prevalence is on a steady rise, management of IBD... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy of fecal microbiota therapy in steroid dependent ulcerative colitis: a real world intention-to-treat analysis
-
Sood A, Mahajan R, Juyal G, Midha V, Grewal CS, Mehta V, Singh A, Joshi MC, Narang V, Kaur K, Sidhu H
- KMID: 2438446
- Intest Res.
- 2019 Jan;17(1):78-86.
- doi: 10.5217/ir.2018.00089
BACKGROUND/AIMS: Four high-quality randomized controlled trials have proven the efficacy of fecal microbiota transplantation (FMT) in active ulcerative colitis (UC). We assessed the efficacy of FMT in a real-world setting... -
- CITED
-
- Close
- SHARE
-
- Close
- Colitis and Crohn’s Foundation (India): a first nationwide inflammatory bowel disease registry
-
Sood A, Kaur K, Mahajan R, Midha V, Singh A, Sharma S, Puri AS, Goswami B, Desai D, Pai CG, Peddi K, Philip M, Kochhar R, Nijhawan S, Bhatia S, Rao NS
- KMID: 2515479
- Intest Res.
- 2021 Apr;19(2):206-216.
- doi: 10.5217/ir.2019.09169
Background/Aims: The national registry for inflammatory bowel disease (IBD) was designed to study epidemiology and prescribing pattern of treatment of IBD in India. Methods: A multicenter, cross-sectional, prospective registry was... -
- CITED
-
- Close
- SHARE
-
- Close
